📰 Prescience Point News
Page 4 - Prescience Point News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Prescience Point. Real-time updates on events, politics, business and more.
October 27, 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation.
October 27, 2021
/PRNewswire/ -- Prescience Point Capital Management, a research-focused, catalyst-driven investment firm that seeks to earn superior risk-adjusted returns...
May 3, 2021
Urges Shareholders to Vote the WHITE Proxy Card “FOR ALL” Four of MIMEDX’s Director Nominees – Dr. Kathleen Behrens, Mr. Todd Newton, Mr. Timothy Wright, and Dr. Phyllis Gardner Entirely Reconstituted Board and New Management Team Positioned Company for Long-Term Sustainable Growth; Stock Price Appreciation of 237% Since Timothy Wright Selected as CEO Virtual Annual Meeting to Be Held on May 27, 2021 MARIETTA, Ga., May 03, 2021 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (NASDAQ: MDXG) (�...
May 3, 2021
MIMEDX Files Definitive Proxy Materials and Mails Letter to Shareholders Highlighting Actions Taken to Transform MIMEDX and Drive Significant Value for Shareholders May 03, 2021 08:02 ET | Source: MiMedx Group, Inc MiMedx Group, Inc Marietta, Georgia, UNITED STATES Urges Shareholders to Vote the WHITE Proxy Card “FOR ALL” Four of MIMEDX’s Director Nominees – Dr. Kathleen Behrens, Mr. Todd Newton, Mr. Timothy Wright, and Dr. Phyllis Gardner Ent...
April 16, 2021
Prescience Point Capital Management to Nominate Four Highly Qualified Director Candidates to MiMedx Board at 2021 Annual Meeting Sends Letter to Fellow MiMedx Shareholders Citing Boards Failure to Maximize Shareholder Value News provided by Share this article Share this article BATON ROUGE, La., April 16, 2021 /PRNewswire/ -- Prescience Point Capital Management, together with its affiliates ("Prescience Point"), a research-focused, catalyst-driven investment firm, announced today the nominatio...
December 16, 2020
Prescience Point Capital Management Raises Price Target on MiMedx Group to $31 Per Share New Research Indicates That MiMedxs Amniofix Injectable Product Will Be A Blockbuster, Game-Changing Treatment for Knee Osteoarthritis MiMedxs Wound Care Sales Are Poised To Re-Accelerate Over The Coming Quarters Due To Recent Contract And Insurance Wins And A New Product Launch News provided by Share this article Share this article BATON ROUGE, La., Dec. 16, 2020 /PRNewswire/ -- Prescience Point Capital M...